Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Cheung

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2019
Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trialsYasir Alayed, Harvey Quon, Patrick Cheung, et al.
European Urology Oncology|February 4, 2025
Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective TrialsCristian Udovicich, Patrick Cheung, William Chu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective TrialsYasir Alayed, Melanie Davidson, Stanley Liu, et al.
European Urology Oncology|April 27, 2025
Every Other Day or Once a Week: Long-term Oncological Outcomes in the Phase 2 PATRIOT Trial of Prostate Stereotactic Ablative Body RadiotherapyWee Loon Ong, Harvey Quon, Aldrich Ong, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 11, 2022
Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysisPriya Patel, Paula D Robinson, Nora Wahib, et al.
Journal of the National Cancer Institute|July 31, 2014
Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25Patrick Cheung, Sergio Faria, Shahida Ahmed, et al.
European Urology|August 17, 2021
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter StudyPatrick Cheung, Samir Patel, Scott A North, et al.
JAMA Network Open|February 25, 2026
SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate CancerCristian Udovicich, Patrick Cheung, William Chu, et al.
Advances in Radiation Oncology|June 13, 2020
Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate CancerAudrey T Dang, Rebecca G Levin-Epstein, David Shabsovich, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2019
Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapyYasir Alayed, Melanie Davidson, Harvey Quon, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2019
Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trialsYasir Alayed, Harvey Quon, Patrick Cheung, et al.
European Urology Oncology|February 4, 2025
Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective TrialsCristian Udovicich, Patrick Cheung, William Chu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective TrialsYasir Alayed, Melanie Davidson, Stanley Liu, et al.
European Urology Oncology|April 27, 2025
Every Other Day or Once a Week: Long-term Oncological Outcomes in the Phase 2 PATRIOT Trial of Prostate Stereotactic Ablative Body RadiotherapyWee Loon Ong, Harvey Quon, Aldrich Ong, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 11, 2022
Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysisPriya Patel, Paula D Robinson, Nora Wahib, et al.
Journal of the National Cancer Institute|July 31, 2014
Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25Patrick Cheung, Sergio Faria, Shahida Ahmed, et al.
European Urology|August 17, 2021
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter StudyPatrick Cheung, Samir Patel, Scott A North, et al.
JAMA Network Open|February 25, 2026
SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate CancerCristian Udovicich, Patrick Cheung, William Chu, et al.
Advances in Radiation Oncology|June 13, 2020
Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate CancerAudrey T Dang, Rebecca G Levin-Epstein, David Shabsovich, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2019
Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapyYasir Alayed, Melanie Davidson, Harvey Quon, et al.
Pageof 15